Avanos (NYSE: AVNS) director Julie Ann Shimer receives 12,003 restricted units

Rhea-AI Filing Summary

Shimer Julie Ann reported acquisition or exercise transactions in this Form 4 filing.

AVANOS MEDICAL, INC. director Julie Ann Shimer reported a compensation-related grant of 12,003 restricted share units on May 8, 2026. Each unit is a contingent right to receive a cash payment equal to the value of one share of Avanos common stock.

These restricted share units were issued to replace units originally granted on January 2, 2025, and will vest when Shimer terminates her service on the company’s Board of Directors. Following this award, she holds 12,003 restricted share units directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Shimer Julie Ann

Role null

Type	Security	Shares	Price	Value
Grant/Award	Restricted Share Units	12,003	$0.00	--

Holdings After Transaction: Restricted Share Units — 12,003 shares (Direct, null)

Footnotes (1)

1. Represents restricted share units issued to the Reporting Person on May 8, 2026. Each restricted share unit represents a contingent right to receive a cash payment equal to the value of one share of the Issuer's common stock. The restricted share units were issued to replace the restricted share units issued to the Reporting Person on January 2, 2025. The restricted share units vest on the date the Reporting Person terminates service on the Issuer's Board of Directors.

Key Figures

Restricted share units granted: 12,003 units Grant price per unit: $0.0000 per unit Underlying common stock equivalent: 12,003 shares value basis +3 more

6 metrics

Restricted share units granted 12,003 units Grant to director on May 8, 2026

Grant price per unit $0.0000 per unit Compensation award, no purchase price

Underlying common stock equivalent 12,003 shares value basis Each unit tied to value of one common share

Vesting condition Vests at Board service termination Units vest when director leaves Board

Units held after transaction 12,003 units Total restricted share units following grant

Transaction code A (Grant, award, or other acquisition) SEC Form 4 transaction classification

Key Terms

Restricted Share Units, contingent right, vest, Form 4

4 terms

Restricted Share Units financial

"Represents restricted share units issued to the Reporting Person on May 8, 2026."

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

contingent right financial

"Each restricted share unit represents a contingent right to receive a cash payment equal to the value of one share"

vest financial

"The restricted share units vest on the date the Reporting Person terminates service on the Issuer's Board of Directors."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shimer Julie Ann

(Last) (First) (Middle)

5405 WINDWARD PARKWAY

(Street)

ALPHARETTA GEORGIA 30004

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AVANOS MEDICAL, INC. [ AVNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Units	(1)	05/08/2026		A		12,003		(2)	(2)	Common Stock	12,003	$0	12,003	D

Explanation of Responses:

1. Represents restricted share units issued to the Reporting Person on May 8, 2026. Each restricted share unit represents a contingent right to receive a cash payment equal to the value of one share of the Issuer's common stock. The restricted share units were issued to replace the restricted share units issued to the Reporting Person on January 2, 2025.

2. The restricted share units vest on the date the Reporting Person terminates service on the Issuer's Board of Directors.

Remarks:

	/s/ John Fischer, as attorney-in-fact for Julie Shimer	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did AVNS director Julie Ann Shimer report?

Julie Ann Shimer reported a grant of 12,003 restricted share units as compensation. Each unit is tied to the value of one Avanos common share and replaces a prior award granted on January 2, 2025.

How many restricted share units did AVNS grant to Julie Ann Shimer?

Avanos granted Julie Ann Shimer 12,003 restricted share units. These units represent a contingent right to receive cash equal to one share of Avanos common stock for each unit, subject to future vesting conditions.

Are the AVNS restricted share units an immediate stock purchase for Julie Ann Shimer?

No, the restricted share units are not an immediate stock purchase. They are a contingent right to receive a cash payment equal to the value of one Avanos common share per unit when they eventually vest.

When do Julie Ann Shimer’s AVNS restricted share units vest?

The restricted share units vest when Julie Ann Shimer terminates her service on Avanos Medical’s Board of Directors. Until that date, they remain unvested, serving as a long-term incentive tied to her board tenure.

What happened to the AVNS restricted share units granted on January 2, 2025?

The May 8, 2026 award of 12,003 restricted share units was issued to replace the restricted share units originally granted on January 2, 2025, effectively substituting the prior grant with this new cash-settled unit award.

How many restricted share units does Julie Ann Shimer hold after this AVNS transaction?

After this transaction, Julie Ann Shimer holds 12,003 restricted share units directly. This figure reflects the new grant reported in the Form 4 and represents her current reported restricted unit holdings in the filing.